Weill Cornell Medicine | NewYork-Presbyterian — New York, New York

Weill Cornell Medicine | NewYork-Presbyterian is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Weill Cornell Medicine | NewYork-Presbyterian has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer, Deep Venous Thrombosis, Pulmonary Embolism.

Sponsors: OncoTherapy Science, Inc., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Marker Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Weill Cornell Medicine | NewYork-Presbyterian?

Weill Cornell Medicine | NewYork-Presbyterian has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Weill Cornell Medicine | NewYork-Presbyterian conducted?

Weill Cornell Medicine | NewYork-Presbyterian has 3 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer, Deep Venous Thrombosis, Pulmonary Embolism.

Is Weill Cornell Medicine | NewYork-Presbyterian accredited by Crixeo Health?

Weill Cornell Medicine | NewYork-Presbyterian has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Weill Cornell Medicine | NewYork-Presbyterian?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.